0001181431-13-030749.txt : 20130524
0001181431-13-030749.hdr.sgml : 20130524
20130524164956
ACCESSION NUMBER: 0001181431-13-030749
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130523
FILED AS OF DATE: 20130524
DATE AS OF CHANGE: 20130524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pascoe Richard W
CENTRAL INDEX KEY: 0001343266
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22245
FILM NUMBER: 13872707
MAIL ADDRESS:
STREET 1: C/O SOMAXON PHARMACEUTICALS, INC.
STREET 2: 10935 VISTA SORRENTO PARKWAY, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APRICUS BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001017491
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870449967
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11975 EL CAMINO REAL,
STREET 2: SUITE 300
CITY: SAN DIEGO,
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 222-8041
MAIL ADDRESS:
STREET 1: 11975 EL CAMINO REAL,
STREET 2: SUITE 300
CITY: SAN DIEGO,
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: NEXMED INC
DATE OF NAME CHANGE: 19970311
4
1
rrd381345.xml
FORM 4
X0306
4
2013-05-23
0
0001017491
APRICUS BIOSCIENCES, INC.
APRI
0001343266
Pascoe Richard W
11975 EL CAMINO REAL
SUITE 300
SAN DIEGO
CA
92130
1
1
0
0
Chief Executive Officer
Common Stock
2013-05-23
4
P
0
35000
2.85
A
35000
D
Common Stock Warrant
3.40
2013-05-23
4
P
0
35000
2.85
A
2013-05-29
2018-05-29
Common Stock
17500
35000
D
Purchase in accordance with the Underwriting Agreement, by and between Apricus Biosciences, Inc. and Lazard Capital Markets LLC, dated May 23, 2013.
Each warrant is exercisable for 0.50 shares of common stock.
/s/ Richard W. Pascoe
2013-05-24